Getinge and CellRev Launch Livit ACE Platform
Getinge has partnered with the bioprocessing company CellRev in the development of a continuous cell processing platform called Livit ACE…
Navigate Today Shape Tomorrow
Getinge has partnered with the bioprocessing company CellRev in the development of a continuous cell processing platform called Livit ACE…
There is a real opportunity for Artificial Intelligence to maximise Life Sciences companies’ investment in regulatory data management. ArisGlobal’s Agnes…
Caris Discovery, the therapeutic research arm of Caris Life Sciences announced a multi-year strategic partnership with Merck KGaA, Darmstadt, Germany, which…
Written by: Justin Wilson at Withers & Rogers. With more gene therapy clinical trials securing authorisation and getting underway globally, innovators are…
Astellas Ireland, a wholly owned subsidiary of Astellas Pharma, held a ceremony to mark the breaking of the ground and start…
Corteria Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the development of transformative therapies for heart failure and obesity, have announced the…
Roche have announced that the U.S. FDA have approved the cobas Malaria test for use on the cobas 6800/8800 Systems. This approved test…
Written by: Maria Elena Gasperini, Director of Sustainability Life Sciences, Jacobs. As part of the global effort to address climate change,…
Written by: Paul Knight, Managing Director of CME Automation Systems One of the biggest challenges facing the life sciences industry…
Bespak have announced the completion of the transaction to separate Recipharm’s former Advanced Delivery Systems Business Unit from the Recipharm Group…
UK-based contract development and manufacturing organisation Upperton Pharma Solutions was joined by Oxford/AstraZeneca COVID-19 vaccine co-inventor Professor Dame Sarah Gilbert, biotech…
Ubiquigent Limited, a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high…
Bio-Rad Laboratories have announced the launch of validated antibodies for rare cell and circulating tumour cell (CTC) enumeration. Validated for…
Viking Therapeutics have announced positive results from the company’s Phase 1 multiple ascending dose (MAD) clinical trial of an oral…
MSD have announced that the U.S. FDA has approved sotatercept-csrk (U.S. Brand Name: WINREVAIR, for injection, 45mg, 60mg) for the treatment of…
Aragen has operationalised the first phase of its biologics manufacturing facility in Bangalore, India through its 100% subsidiary, Aragen Biologics Pvt…
Akebia Therapeutics have announced that the U.S. Food and Drug Administration (FDA) has approved Vafseo (vadadustat) tablets for the treatment of anemia due to…
Blackstone have announced a new collaboration with Moderna through a development and commercialisation funding agreement where funds managed by Blackstone Life Sciences…
BrePco Biopharma (BPCO) have announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted…
Lonza have announced an expansion of its service offering for spray-drying of proteins for pulmonary delivery. The new offering provides clinical…
Otsuka Pharmaceutical Europe and H. Lundbeck A/S have announced that the European Commission (EC) has approved Abilify Maintena 960 mg (aripiprazole) as a…
Exothera has launched its game-changing nucleic acids service offering, powered by the world’s first continuous-batch RNA production platform, Ntensify. Developed by Exothera sister…
PhaSER Biomedical has agreed a long-term partnership with the Sanders Tri-Institutional Therapeutic Discovery Institute (TDI) to enhance the institute’s groundbreaking pre-clinical…
Actylis and Novo Nordisk Pharmatech A/S have entered into an agreement for the distribution of pharmaceutical grade Benzalkonium Chloride (BKC)…
Vicore Pharma Holding AB have announced FDA Breakthrough Device Designation status for Almee, a 9-week digital cognitive behavioural therapy (CBT), to be used as an…
Cognizant is advancing the application of generative AI (gen AI) technology with the NVIDIA BioNeMo platform to solve complex challenges of…
Lonza have announced it has signed an agreement to acquire the Genentech large-scale biologics manufacturing site in Vacaville, California (US) from…
It’s long been a concern for scientists and regulators that drugs are intended for use by anyone but are predominantly…
Hovione and GEA have announced the next stage of their partnership, with new development agreements, the launch of the ConsiGma CDC flex as…
Novo Nordisk have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a…
Owkin, the first end-to-end TechBio unicorn that provides AI-driven precision drug discovery, development and diagnostics by matching new biology to new…
Element have announced the launch of its Rapid Response Pharmaceutical Testing Service from its Manchester Life Sciences laboratory. This offering will…
SolasCure has been awarded a highly competitive Biomedical Catalyst Grant for industry-led research and development (R&D) from Innovate UK. The…
Ahead of World Tuberculosis (TB) Day, which is marked on 24 March, WHO has released an investment case for TB screening…
Roquette have announced an agreement to acquire IFF Pharma Solutions, a worldwide producer of excipients for oral dosage solutions. The combination…
Bristol Myers Squibb have announced that it has successfully completed its acquisition of Karuna Therapeutics, Inc. With the acquisition’s completion, Karuna…
Pfizer Inc have announced that the European Commission (EC) has granted marketing authorisation for the company’s 20-valent pneumococcal conjugate vaccine, marketed in…
Novartis recently announced it broke ground for the expansion of its biopharmaceutical manufacturing plant in Singapore. The $256 million investment will…
AstraZeneca have announced that it has entered into a definitive agreement to acquire Amolyt Pharma, a clinical-stage biotechnology company focused on…
Mission Therapeutics have announced it has raised £25.2 million to progress the clinical development of its drug candidates. The financing was jointly…
The RESILIENCE Centre of Excellence for UK Medicines Manufacturing Skills will deliver training and outreach materials and programmes that addresses…
Biocon Biologics Limited have announced a long-term commercial collaboration with Eris Lifesciences to expand patient access to its portfolio of…
Madrigal Pharmaceuticals have announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Rezdiffra (resmetirom) in conjunction with diet…
Zephyr AI, Inc. have announced it has successfully closed a $111 million Series A funding round with participation from Revolution Growth,…
Further investment in high quality lab and research space is vital if the life sciences sector in Scotland is to…
IFM Therapeutics have announced that Novartis has exercised its option to acquire all of the outstanding capital stock of IFM Due,…
Ricoh Company, Ltd. have announced a non-exclusive licensing agreement in the USA and Japan with ERS Genomics Limited for access to…
Allumiqs and Prolytix, have announced their long-term, strategic partnership focused on delivering collaborative and integrated solutions to help customers optimise drug development…
SGD Pharma recently started a two-week trial using 100% hydrogen burners for industrial-scale glass production. The trial, conducted at SGD Pharma’s Saint-Quentin-Lamotte (SQLM)…
Merck, known as MSD outside of the United States and Canada, have announced the completion of the acquisition of Harpoon…
Novo Nordisk have announced that the US Food and Drug Administration (FDA) has approved a label expansion for Wegovy based on…
Ubiquigent Limited have announced an agreement with Nanna Therapeutics. Under the terms of the agreement, Ubiquigent will provide Nanna with access…
PhaseV, a pioneer in causal machine learning (ML) for clinical trial analysis and optimisation, announced it has partnered with oncology-…
The World Health Organization’s (WHO) latest HIV Drug Resistance (HIVDR) Report tells us where drug resistance is growing and offers…
Roche and Alnylam recently announced that the Phase II KARDIA-2 study of zilebesiran, an investigational RNAi therapeutic in development for the…
Written by: Mike Ludlow, Market Development Manager, Life Sciences; Element Materials Technology. The growth in the development of biopharmaceuticals has impacted…
On International Women’s Day March 8th, it’s a prime opportunity to reflect on the status of women in the pharmaceutical…
Samsung BioLogics and UCB have agreed to an additional drug substance manufacturing deal under which SBL will also produce UCB’s…
GSK have announced positive headline results from an interim analysis of the DREAMM-8 phase III head-to-head trial evaluating Blenrep (belantamab mafodotin), in combination…
Gilead Sciences and Merus N.V. have announced a research collaboration, option and license agreement to discover novel dual tumour-associated antigens (TAA) targeting trispecific…
Keytruda is one of the most significant and popular pharmaceuticals in the world. We at EPM have attempted to answer…
AstraZeneca has outlined plans to invest £650 million in the UK – helping boost the UK’s world leading Life Sciences…
Novo Nordisk have announced the headline results from the kidney outcomes trial FLOW. The announcement follows the decision to stop the…
GSK plc have announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as…
Heidelberg Pharma AG and HealthCare Royalty have announced that they have signed a royalty financing agreement. Formal closing conditions that are…
Bayer has acquired the exclusive marketing rights for acoramidis in Europe from Eidos Therapeutics Inc., BridgeBio International GmbH and BridgeBio…
GSK plc has announced that Dr Jeannie Lee has been appointed to the Board of the Company as a Non-Executive…
Image credit: Adragos Pharma. The Prange Group and its affiliate Adragos Pharma, one of Europe’s fastest growing CDMOs, has completed…
Pfizer Inc. has outlined its strategic priorities for the newly formed Oncology organisation — and how its pipeline, Oncology expertise, and…
This is the third and last in a series of interviews with a collection of subject matter experts (SMEs) operating…
Herbert Altmann, PhD, Head of Market Access, Pricing and Reimbursement at Cencora (formerly AmerisourceBergen). Jai: How early will pharmaceutical companies…
Boston Scientific Corporation have announced it has received U.S. Food and Drug Administration (FDA) approval for the AGENT Drug-Coated Balloon (DCB), which…
Clinigen have launched a new campaign called ‘What is Possible?’ to help empower patients and medical professionals to ask what…
PharmaKure, a clinical stage pharmaceutical company developing precision medicines for Alzheimer’s Disease (AD) and other neurodegenerative diseases, have announced a new…
Neomorph, Inc. have announced it has entered into a collaboration and licensing agreement with global healthcare company Novo Nordisk to discover, develop…
Amneal Pharmaceuticals, Inc. have announced that it has entered into an exclusive licensing agreement with Zambon Biotech SA, part of…
Bristol Myers Squibb has completed its acquisition of RayzeBio, Inc. With the completion of the acquisition, RayzeBio shares have ceased…
Telix has entered into an agreement to acquire IsoTherapeutics Group, LLC (IsoTherapeutics), a specialty radiopharmaceutical development and bioconjugation firm, based…
Aptamer Group plc announces the second phase of its on-going partnership with Neuro-Bio, an Oxfordshire-based biotechnology company with a therapeutic focus…
SGD Pharma has achieved a gold medal in EcoVadis’ 2024 sustainability ratings. Building upon previous years, SGD Pharma’s score of 77…
Today’s healthcare market is overflowing with myriad products, making it increasingly difficult for businesses to stand out. This is particularly…
Grifols has announced that Biotest’s positive topline results from AdFIrst, its phase 3 clinical trial of its fibrinogen concentrate (FC), BT524, advance this…
PhaSER Biomedical (PhaSER) has received a grant totalling $2.3m to continue its pioneering work in accelerating drug discovery and development…
MIP Discovery has closed a £7m Series A financing round led by Mercia Ventures. Existing investor Calculus Capital also participated in the…
A team of academics from Aston University, the University of Nottingham and King’s College London has secured a £1.7m grant…
RSSL have announced plans to launch its new Innovation Hub, a dedicated platform to help small- and medium-sized biotech organisations de-risk…
BioAscent has opened its state-of-the-art protein production facility in an event officiated by Professor Michael Barrett OBE. The new facility…
Refrigeration accounts for a high proportion of overall site energy costs, most notably cooling for pharmaceutical processes where up to…
French startup Bioptimus emerged from stealth following a seed funding round of $35M. Under the leadership of Professor Jean-Philippe Vert, PhD, Bioptimus…
NorthSea Therapeutics B.V. have announced the dosing of the first patient in its Phase 2a clinical trial of Orziloben (NST-6179) in intestinal…
The advance of the sublimation front during primary drying in a freeze-drying process is one of the most critical parameters…
Electronic production records give you a holistic view of your manufacturing operations, which is essential to achieving your key performance indicators…
Freudenberg Medical is to establish a second manufacturing site in Costa Rica. With this $25 million investment the company is expanding…
GSK have announced that it has completed the acquisition of Aiolos Bio, a clinical-stage biopharmaceutical company focused on addressing the…
The biopharmaceutical industry is undergoing a shift propelled by intricate biologics and their impact on global healthcare. With advancements in…
FUJIFILM Healthcare Europe has unveiled the ECHELON Synergy, a revolutionary MRI scanner for efficient, high performance imaging with optimal patient comfort. The 1.5…
The drug delivery and packaging industry is poised for a promising 2024 following Pharmapack Europe held January 24th and 25th. Pharmapack recorded…
Written by: Bryan Hill (Global / Americas), Gaga Syal (GGM) & Rohit Alimchandani (UK) – Cognizant. For life sciences organisations, the pressure to speed…
Written by: Andy Clarke, Country Manager (UK), YSDS. Low Volume, High Value The low volume life science market has significant…
Artificial intelligence (AI) has the potential to radically alter the field of healthcare, and it’s already enhancing medical imaging. Penny…
Osivax have announced that the first participant has been vaccinated in its new Phase 1 trial (NCT06128382) evaluating OVX033, a broad-spectrum sarbecovirus…
Chiesi Ltd, a Manchester-based biopharmaceutical company, has today announced a carbon neutral respiratory portfolio. Chiesi has already committed to a series…
Ipsen have announced that the U.S. FDA has approved the supplemental new drug application for Onivyde (irinotecan liposome injection) plus oxaliplatin, fluorouracil and…
AbbVie has completed its acquisition of ImmunoGen. “Together with ImmunoGen, we have the potential to continue redefining the standard of care…
Biogen Inc. have announced the European Commission (EC) has authorised SKYCLARYS (omaveloxolone) for the treatment of Friedreich’s ataxia (FA) in adults and…
PanTera, the Belgian joint venture created by IBA and SCK CEN to secure large-scale production of alpha-emitting radioisotopes, have announced the…
Chanelle Pharma has been sold by its founder Michael H Burke to Exponent, a leading private equity firm. Headquartered in Loughrea,…
Novartis announced that, following positive advice from the Scottish Medicines Consortium (SMC), Cosentyx (secukinumab) is now available in Scotland on the…
Jazz Pharmaceuticals plc and Redx Pharma plc have signed a definitive agreement under which Jazz will acquire Redx’s KRAS (Kirsten rat sarcoma…
Zetta Genomics, has expanded its second seed round – securing an additional £1.8 million and strengthening investor expertise. Demonstrating continued…
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award up to $1.8 million to biotechnology company, Visby Medical, to develop a…
Quibim, a global company pioneering imaging biomarkers for precision medicine, is announcing the launch of a new product, QP-Insights, which…
Samsung Biologics have announced it has signed a partnership agreement with LegoChem Biosciences, a biotech company pioneering the research and…
Nicholas Panico, President Scientific and Regulatory Affairs, Symbio Proinnovera Our skin is our body’s first line of defence against the…
Telix has announced it has entered into an agreement to acquire QSAM Biosciences, Inc. and its lead investigational drug Samarium-153-DOTMP (153Sm-DOTMP). QSAM…
BridgeBio Pharma, Inc. and Kyowa Kirin Co., Ltd have announced a partnership wherein BridgeBio’s affiliate, QED Therapeutics, grants Kyowa Kirin…
AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell therapy platforms in…
Accent Therapeutics have announced the closing of a $75 million Series C financing. The financing was led by Mirae Asset Capital…
Aston University has hosted an event to celebrate the launch of SPARK The Midlands, a network which aims to bridge the…
Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, and Sanofi Vaccines, have…
Novo Nordisk have announced that the company has agreed to acquire three fill-finish sites from Novo Holdings A/S (Novo Holdings) in…
Enterprise Therapeutics Ltd, a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients…
Cristalia’s human growth hormone will be administered with CRISPEN. Approved by ANVISA1, CRISPEN is part of Nemera’s state-of- the-art pen injector…
We caught up with LogiPharma’s Will Robinson to discuss one of their recent sustainability reports, supply chains, and what the…
Vivet Therapeutics have announced the financing of €4.9 million received from the French government to advance the development of a gene…
Central Research Laboratories (CRL) have announced that due to increased and steady demand for its Single-Use Beta Bags, it will be expanding…
Joseph Boyd, PhD., and Vi Chu, Ph.D., Cell Biology R&D, Life Science Business of Merck. Organoids—complex, multicellular, 3-dimensional in vitro cell models…
Reaching key milestones with pivotal shifts in treatment modalities and the reshaping of drug development, manufacturing and distribution – 2023…
NeoPhore Limited have announced a further extension of £9.6m (approx. USD $12.2m) to its Series B financing round. With participation from its existing…
Scottish biopharmaceutical company Aurum Biosciences has raised almost £730,000 in the first tranche of a new round of equity funding…
Almirall S.A., have announced a strategic partnership with Microsoft to drive innovation and digital transformation, advance the research of medical…
Matisse Pharmaceuticals B.V., a clinical stage company developing a medicinal product for the treatment of sepsis, have announced topline results…
We at EPM HQ, with the help of ramarketing, caught up with Uwe Hanenberg, Head of Product Development, Oral Solid…
ACG, the world’s largest integrated supplier and service provider to the pharmaceutical industry, celebrated the inclusion of its capsule manufacturing…
FUSE-AI GmbH, an innovator in artificial intelligence for radiology, have announced its AI software “Prostate.Carcinoma.ai” has received EU Medical Device…
TekniPlex Healthcare is expanding its capabilities portfolio by commencing multilayer blown film manufacturing in a cleanroom environment. Located at TekniPlex Healthcare’s…
Genetic Design and Manufacturing Corporation (GDMC), a design and manufacturing organisation that focuses on next generation advanced genetic therapies, have announced…
Sharp has announced that it has committed to the Science Based Targets initiative (STBi) in a significant step towards reducing greenhouse…
Kyowa Kirin Co., Ltd. has successfully completed the acquisition of Orchard Therapeutics. The acquisition of all outstanding shares of Orchard Therapeutics…
Cognizant have announced an expanded agreement with Takeda a global biopharmaceutical company, to support the company’s digital transformation strategy by reinforcing and supporting its…
Synnovation Therapeutics, a precision medicine company developing small molecule therapies optimised to achieve best-in-class pharmacology against highly validated disease targets,…
Science Card, the home of Britain’s first e-money current accounts dedicated to accelerating science and innovation, has announced the launch…
Cherwell, cleanroom microbiology solutions expert, has launched the Redipor Beta Bag to ensure the safe transfer of ready-to-use gamma-irradiated prepared media…
Sheffield Hallam University’s Advanced Wellbeing Research Centre (AWRC) has unveiled the companies set to join the 2024 cohort for its…
Virios Therapeutics, Inc have announced plans for advancing IMC-2 (combination of valacyclovir and celecoxib) as a treatment for the fatigue, orthostatic intolerance…
PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), based at the Babraham Research Campus, and the…
BioLizard have announced the incorporation of BioLizard SA and the opening of new offices at Biopôle in Lausanne, home to one…
Pfizer’s Talazoparib has been recommended by UK NICE for advanced breast cancer. The recommendation reverses NICE’s earlier draft decision not…
SGD Pharma has announced the opening of a new siliconisation operation at its state-of-the-art Saint-Quentin Lamotte (SQLM) plant. The company enhances its…
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is awarding US$633k to Intravacc to develop a vaccine that prevents Neisseria gonorrhoeae bacterial…
Brown Gibbons Lang & Company (BGL) is pleased to announce the sale of Source Stability Storage, a UK-based biotech storage facility owned by parent company Source…
Sun Pharmaceutical Industries Limited and Taro Pharmaceutical Industries Ltd have announced that they have entered into a definitive merger agreement in which…
BridgeBio Pharma have announced strategic financing from Blue Owl Capital and Canada Pension Plan Investment Board, through a wholly owned…
Comanche Biopharma Corp have announced the closing of an oversubscribed $75 million Series B financing to advance its mission to develop…
Voydeya (danicopan) has been approved in Japan for the treatment of paroxysmal nocturnal haemoglobinuria (PNH). It is indicated in Japan in…
Kindeva Drug Delivery have announced that it has acquired Summit Biosciences Inc., an intranasal drug-delivery contract development and manufacturing organisation (CDMO), from its…
Synendos Therapeutics AG, a world leader in innovative Endocannabinoid System (ECS) treatments, has announced that it has received approval from the European…
The Industrial Biotechnology Innovation Centre (IBioIC) has been awarded long-term investment from the Scottish Funding Council (SFC), securing its position…
Oral solid dosage (OSD) forms are commonly used to administer small molecule drugs to patients, facilitating ease of administration to…
Elsevier, a global leader in scientific information and data analytics, has launches Scopus AI – a generative AI product to help researchers…
A new modular automation system for clinical trials drug delivery – now in operation at the Medical Manufacturing Innovation Centre…
The Bill & Melinda Gates Foundation have announced its largest annual budget to date as it works toward the goal…
Limerston Capital has completed the acquisition of Source BioScience’s Stability Storage business, underlining its commitment to the healthcare, testing and…
John Cardone, Marketing Manager, Custom Antibodies, Bio-Rad Laboratories. Antibody-based therapeutics are a powerful modality developed for a range of diseases,…
Eisai Co., Ltd. and Biogen Inc. have announced that humanised anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody “LEQEMBI” has been approved in China as…
The World Health Organization (WHO) has certified Cabo Verde as a malaria-free country, marking a significant achievement in global health.…
Ji Xing Pharmaceuticals a clinical-stage biopharmaceutical company committed to bringing innovative medicines to underserved patients with serious and life-threatening diseases, have…
Cereno Scientific have announced that an agreement has been signed with CordenPharma. CordenPharma is contracted to manufacture drug candidate CS1 in larger…
Evotec SE has joined forces with the Crohn’s & Colitis Foundation, the leading non-profit organisation focused on both research and…
The ADVANCE (Accelerating Discovery: Actionable NASH Cirrhosis Endpoints) study will be the most detailed observational study of its kind enrolling…
Merck, known as MSD outside of the United States and Canada, and Harpoon Therapeutics, Inc have announced that the companies have entered into a definitive…
WuXi AppTec have announced the commissioning of two new peptide manufacturing plants, one at its Changzhou facility and another at the new Taixing…
Iktos and Nerviano Medical Sciences S.r.l have announced a collaboration agreement in AI for unprecedented kinase project. As per the…
MOMA Therapeutics have announced a strategic collaboration and licensing agreement with Roche. This partnership provides Roche with access to MOMA’s…
AbbVie and Umoja Biopharma (Umoja), an early clinical-stage biotechnology company, have announced two exclusive option and license agreements to develop multiple…
For the first in the FemTech series on the MedTalk Podcast, Medical Plastics News editor Olivia Friett is joined by…
From 1 January 2024, developers of new medicines can now submit applications via the MHRA’s new, International Recognition Procedure (IRP). The…
MediLink Therapeutics have announced that it has entered into a worldwide collaboration and license agreement with Roche on the development of a…
Oragenics announces it has completed its previously announced acquisition of assets related to Odyssey Health’s proprietary neurological drug therapies and technologies. The…
Elpiscience Biopharma and Astellas Pharma have announced a research collaboration and license agreement for novel bispecific macrophage engagers, ES019 and another program.…
Voyager Therapeutics have announced a strategic collaboration and capsid license agreement with Novartis Pharma AG, a subsidiary of Novartis AG to advance potential…
The Rhenus Group announces the successful certification of the Good Distribution Practice (GDP) for its Air & Ocean Division in…
Getinge has introduced a modular and fully automated load handling solution for seamless integration with the company’s GEV terminal sterilisers. In…
Josh Ludwig, Global Commercial Director, ScaleReady Over the past decade, the landscape of cell and gene therapy (CGT) has experienced…
In the dynamic landscape of pharmaceutical manufacturing, striving for sustainable practices has transitioned from a choice to an imperative. The…
Signal detection in post-market drug monitoring has changed little in 70 years, but now that shake-up is coming in the…
Pfizer have announced the successful completion of its acquisition of Seagen Inc, a global biotechnology company that discovers, develops and commercialises…
FUJIFILM Corporation announces the investment of USD 200 million in two subsidiaries to significantly expand global cell therapy contract development and…
Campbell Bunce, Chief Scientific Officer (CSO) and Cambridge Site Head at Abzena Antibody-drug conjugates (ADCs) already sit close to the…
Priya Baraniak, Ph.D, Chief Business Officer and Dominic Mancini, VP Operations at OrganaBio explored early cryopreservation as a stepping stone to sustainable…
Typically, Q&A’s are focused on a single topic or a single individual. To keep things interesting, here at EPM HQ,…
SGD Pharma has been a leader in the moulded glass packaging market for a significant number of years. Central to…
The annual Pharmapack Drug Delivery Innovation Index is released ahead of Europe’s premier drug delivery and packaging event, Pharmapack Europe 2024. The results…
Alkermes plc have announced that it has entered into a definitive agreement to sell its development and manufacturing facility in Athlone, Ireland to…
ACG, the world’s largest integrated supplier and service provider to pharmaceutical industry celebrated the inclusion of its capsule manufacturing facility…
Owkin, a French-American biotechnology company that applies artificial intelligence (AI) to drug discovery, development, and diagnostics, have announced that it…
James Sheppard, Managing Director (UK&I) at Kadans. Since the pandemic, the life sciences industry has experienced highs and lows. From…
The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax’s adjuvant technology, has been…
AstraZeneca and Ionis’ Wainua (eplontersen) has been approved in the US for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in…
The Novo Nordisk Foundation is committing up to DKK 1.8 billion (USD 260 million) to establish a research and vaccine…